Opportunities and challenges in the collaborative development of laboratory medicine and lifeomics
10.3760/cma.j.cn114452-20230716-00008
- VernacularTitle:检验医学与生命组学协同发展的机遇和挑战
- Author:
Xiaobo YU
1
;
Aihua SUN
;
Yan WANG
;
Fuchu HE
Author Information
1. 医学蛋白质组国家重点实验室 国家蛋白质科学中心-北京（凤凰中心）北京生命组学研究所 北京蛋白质组研究中心，北京 102206
- Keywords:
Laboratory medicine;
Lifeomics;
Proteomics
- From:
Chinese Journal of Laboratory Medicine
2024;47(1):7-13
- CountryChina
- Language:Chinese
-
Abstract:
With the maturation of proteomics technologies in recent years, proteomics has made significant achievements in early detection of major diseases, disease classification, drug target discovery, and other fields. To explore the important role of proteomics, especially proteomics-based cutting-edge lifeomics technologies, in promoting the development of precision laboratory medicine and to discuss the opportunities and challenges faced during the clinical translation of innovative outcomes, the National Center for Protein Sciences-Beijing invited renowned experts and scholars in laboratory medicine, lifeomics, and precision medicine. The discussions revolved around the collaborative development of laboratory medicine and lifeomics, the future trends of new technologies in clinical laboratory testing, the innovation and development of lifeomics in laboratory medicine, the translational application of proteomics technologies in laboratory medicine, and the opportunities and challenges in the industrialization of proteomics achievements. All participants agreed that proteomics provides new directions and opportunities for precision diagnosis and treatment of diseases. However, close collaboration between academia, hospitals and industry is required. Additionally, challenges such as clinical applicability of equipment, standardization of detection methods and data, cost and quality control, talent cultivation, and the industrialization pathway need to be addressed.
